Allez à nos transactions
Soins de la Santé | TMT

ScreenPoint Medical has raised US$28 million in a Series C investment round led by Insight Partners

July 2021 — Netherlands-based ScreenPoint Medical, an AI technology company that develops advanced image recognition and machine learning software to improve early detection of breast cancer, has raised US$28 million (€24 million) in a Series C funding round led by New York-based global venture capital and private equity firm Insight Partners to further develop its technology and accelerate commercial growth of the company’s Transpara AI breast care software.

Founded in 2014 by Professor Nico Karssemeijer and Professor Sir Michael Brady and based in Nijmegen, the Netherlands, ScreenPoint Medical develops and markets innovative machine learning solutions to improve breast cancer screening and diagnosis. With its market-leading AI solution Transpara, ScreenPoint Medical supports radiologists in evaluating mammograms to detect breast cancer and allows them to improve the quality and efficiency of breast cancer screening. Transpara is currently used in over 200 clinics in 25 countries worldwide.

Insight Partners is a US-based venture capital and private equity firm with more than US$30 billion in capital commitments. With its experience and track record of investing in high-growth technology and software companies that drive transformative change in their industries, Insight Partners is ideally situated to support ScreenPoint Medical with its endeavors. Alongside Insight Partners, University Radiology Group, one of the largest providers of sub-specialty radiology and teleradiology services in the United States, participated in the investment round. Existing investors, including ScreenPoint Medical’s founders Siemens Healthineers and Oost NL, will continue to support the company in its further growth and development.

Our role in the transaction

Oaklins’ team in the Netherlands acted as the exclusive advisor to the shareholders and management of ScreenPoint Medical.

About ScreenPoint

ScreenPoint was founded in 2014 as a spin-off from Radboud University Medical Center in Nijmegen, the Netherlands, to develop and bring to market innovative machine learning solutions to improve breast cancer screening and diagnosis. With an exceptional team of specialists in machine learning, image analysis and breast imaging, ScreenPoint developed the market-leading AI solution Transpara for reading mammograms and breast tomosynthesis.

About Insight Partners

Insight Partners is a leading global venture capital and private equity firm investing in high-growth technology and software ScaleUp companies that are driving transformative change in their industries. Founded in 1995, Insight Partners has invested in more than 400 companies worldwide and has raised through a series of funds more than US$30 billion in capital commitments. Insight's mission is to find, fund and work successfully with visionary executives, providing them with practical, hands-on software expertise to foster long-term success. Across its people and its portfolio, Insight encourages a culture around a belief that ScaleUp companies and growth create opportunity for all.

«We are delighted to welcome Insight Partners as a new shareholder of ScreenPoint Medical. Their broad experience and network within the medical technology sector will enable us to further develop and commercialize our AI solution. The support and guidance of the Oaklins team, together with their experience in the medical imaging space, has proven extremely valuable throughout this process.»

Nico Karssemeijer

Founder and CEO

Contacter l'équipe de la transaction

Robert Boersma

Conseiller senior
Amsterdam, Pays-Bas
Oaklins Netherlands

Martijn de Win

Directeur
Amsterdam, Pays-Bas
Oaklins Netherlands

Robbert Bon

Analyste principal
Amsterdam, Pays-Bas
Oaklins Netherlands

Transactions connexes

Be-Cloud has been acquired by PSG Equity
Placements Privés | TMT

Be-Cloud has been acquired by PSG Equity

Be-Cloud, backed by B&Capital since 2021, has been acquired by PSG Equity, a leading growth equity firm specializing in software and technology-enabled services. The transaction marks the full exit of B&Capital and the reinvestment of Be-Cloud’s founders, Lenny and Sébastien Vercruysse, alongside PSG Equity.

En apprendre plus
BIG BIO Herlev and BIG BIO Nordhavn have been acquired by Nordisk Film Biografer
TMT

BIG BIO Herlev and BIG BIO Nordhavn have been acquired by Nordisk Film Biografer

BIG BIO Herlev and BIG BIO Nordhavn, two premium cinemas in the Copenhagen area, have been acquired by Nordisk Film Biografer, part of Nordisk Film, which is owned by Egmont. The acquisition expands Nordisk Film Biografer’s presence in the Danish cinema market and strengthens its premium cinema offering, adding two established venues to its portfolio.

En apprendre plus
Freeway Fleet Systems has been acquired by Movement Software
TMT

Freeway Fleet Systems has been acquired by Movement Software

Freeway Fleet Systems has been acquired by Movement Software, strengthening its position as a leading provider of fleet management and maintenance software while expanding the group’s presence into the UK market. As a strategic consolidator focused on transportation and mobility software, Movement Software will benefit from immediate product and customer synergies, with Freeway providing a strong platform for further geographic expansion across key fleet end markets.

En apprendre plus